Evonik Industries AG (EVK) - Net Assets
Based on the latest financial reports, Evonik Industries AG (EVK) has net assets worth €8.17 Billion EUR (≈ $9.56 Billion USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€17.98 Billion ≈ $21.02 Billion USD) and total liabilities (€9.81 Billion ≈ $11.47 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €8.17 Billion |
| % of Total Assets | 45.46% |
| Annual Growth Rate | 1.5% |
| 5-Year Change | -12.78% |
| 10-Year Change | 5.47% |
| Growth Volatility | 11.7 |
Evonik Industries AG - Net Assets Trend (2013–2025)
This chart illustrates how Evonik Industries AG's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Evonik Industries AG (2013–2025)
The table below shows the annual net assets of Evonik Industries AG from 2013 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €8.17 Billion ≈ $9.56 Billion |
-10.18% |
| 2024-12-31 | €9.10 Billion ≈ $10.64 Billion |
+1.27% |
| 2023-12-31 | €8.99 Billion ≈ $10.51 Billion |
-18.72% |
| 2022-12-31 | €11.06 Billion ≈ $12.93 Billion |
+17.97% |
| 2021-12-31 | €9.37 Billion ≈ $10.96 Billion |
+15.72% |
| 2020-12-31 | €8.10 Billion ≈ $9.47 Billion |
-10.61% |
| 2019-12-31 | €9.06 Billion ≈ $10.59 Billion |
+15.78% |
| 2018-12-31 | €7.83 Billion ≈ $9.15 Billion |
+3.96% |
| 2017-12-31 | €7.53 Billion ≈ $8.80 Billion |
-2.88% |
| 2016-12-31 | €7.75 Billion ≈ $9.06 Billion |
+2.30% |
| 2015-12-31 | €7.58 Billion ≈ $8.86 Billion |
+16.16% |
| 2014-12-31 | €6.52 Billion ≈ $7.62 Billion |
-4.59% |
| 2013-12-31 | €6.84 Billion ≈ $7.99 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Evonik Industries AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 29.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €7.17 Billion | 88.45% |
| Other Components | €937.00 Million | 11.55% |
| Total Equity | €8.11 Billion | 100.00% |
Evonik Industries AG Competitors by Market Cap
The table below lists competitors of Evonik Industries AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SRF Limited
NSE:SRF
|
$7.99 Billion |
|
Sibanye Stillwater Ltd
JSE:SSW
|
$8.00 Billion |
|
Compañía de Minas Buenaventura S.A.A
F:MBU
|
$8.01 Billion |
|
BRENNTAG SE UNSP.ADR/020
F:BNRA
|
$8.01 Billion |
|
Pilgrims Pride Corp
NASDAQ:PPC
|
$7.99 Billion |
|
AptarGroup Inc
NYSE:ATR
|
$7.99 Billion |
|
Full Truck Alliance Co Ltd ADR
NYSE:YMM
|
$7.98 Billion |
|
Hyundai Autoever Corp
KO:307950
|
$7.98 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Evonik Industries AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 9,020,000,000 to 8,110,000,000, a change of -910,000,000 (-10.1%).
- Net income of 265,000,000 contributed positively to equity growth.
- Dividend payments of 545,000,000 reduced retained earnings.
- Share repurchases of 1,000,000 reduced equity.
- New share issuances of 1,000,000 increased equity.
- Other factors decreased equity by 630,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €265.00 Million | +3.27% |
| Dividends Paid | €545.00 Million | -6.72% |
| Share Repurchases | €1.00 Million | -0.01% |
| Share Issuances | €1.00 Million | +0.01% |
| Other Changes | €-630.00 Million | -7.77% |
| Total Change | €- | -10.09% |
Book Value vs Market Value Analysis
This analysis compares Evonik Industries AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.00x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €15.96 | €17.49 | x |
| 2018-12-31 | €16.59 | €17.49 | x |
| 2019-12-31 | €19.25 | €17.49 | x |
| 2020-12-31 | €17.19 | €17.49 | x |
| 2021-12-31 | €19.93 | €17.49 | x |
| 2022-12-31 | €23.55 | €17.49 | x |
| 2023-12-31 | €19.12 | €17.49 | x |
| 2024-12-31 | €19.36 | €17.49 | x |
| 2025-12-31 | €17.40 | €17.49 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Evonik Industries AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 3.27%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.88%
- • Asset Turnover: 0.78x
- • Equity Multiplier: 2.22x
- Recent ROE (3.27%) is below the historical average (9.84%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 30.39% | 16.16% | 0.80x | 2.35x | €1.38 Billion |
| 2014 | 8.84% | 4.40% | 0.82x | 2.44x | €-74.70 Million |
| 2015 | 13.23% | 7.34% | 0.79x | 2.27x | €241.70 Million |
| 2016 | 11.02% | 6.63% | 0.65x | 2.57x | €78.20 Million |
| 2017 | 9.64% | 4.97% | 0.72x | 2.68x | €-26.90 Million |
| 2018 | 12.06% | 6.20% | 0.74x | 2.62x | €159.10 Million |
| 2019 | 23.48% | 16.07% | 0.60x | 2.46x | €1.21 Billion |
| 2020 | 5.80% | 3.81% | 0.58x | 2.61x | €-336.20 Million |
| 2021 | 8.03% | 4.99% | 0.67x | 2.40x | €-182.90 Million |
| 2022 | 4.92% | 2.92% | 0.85x | 1.99x | €-557.40 Million |
| 2023 | -5.22% | -3.05% | 0.77x | 2.24x | €-1.36 Billion |
| 2024 | 2.46% | 1.46% | 0.77x | 2.19x | €-680.00 Million |
| 2025 | 3.27% | 1.88% | 0.78x | 2.22x | €-546.00 Million |
Industry Comparison
This section compares Evonik Industries AG's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $3,247,129,433
- Average return on equity (ROE) among peers: -13.48%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Evonik Industries AG (EVK) | €8.17 Billion | 30.39% | 1.20x | $7.99 Billion |
| GRAPHENE MANUFACT.GROUP (0GF) | $8.69 Million | -107.23% | 0.84x | $152.93 Million |
| Orion Engineered Carbons SA (0OE) | $186.01 Million | 46.73% | 5.76x | $318.41 Million |
| H&R GmbH & Co. KGaA (2HRA) | $222.42 Million | 0.21% | 1.79x | $183.88 Million |
| Dotz Nano Ltd (57N) | $6.76 Million | -76.24% | 0.11x | $1.62 Million |
| EXPLOS. PROD. CHIM.EO 31 (9Z50) | $126.38 Million | 13.98% | 2.40x | $536.15 Million |
| Altech Chemicals Ltd (A3Y) | $20.44 Million | -57.36% | 0.80x | $27.76 Million |
| AlzChem Group AG (ACT) | $89.56 Million | 30.81% | 3.22x | $1.83 Billion |
| AIR LIQUIDE ADR 1/5/EO 11 (AILA) | $26.95 Billion | 13.05% | 0.93x | $103.86 Billion |
| AKZO NOBEL SPONS.ADRS 1/3 (AKUP) | $4.82 Billion | 13.17% | 1.89x | $8.57 Billion |
| BRAIN Biotech AG (BNN) | $41.83 Million | -11.89% | 0.86x | $51.56 Million |
About Evonik Industries AG
Evonik Industries AG operates as a chemicals company in the Asia-Pacific, Europe, the Middle East, Africa, and the Americas. It operates through the Advanced Technologies, Custom Solutions, and Infrastructure segments. The Advanced Technologies segment provides polymers for medical applications; crosslinkers; hydrogen peroxide, a sterilizing agent for cleaning silicon wafers and a bleaching agent… Read more